Fundraising Fox
BioROSA Technologies
Belmont, US · Founded 2018 · Delaware corporation · 3 employees on LinkedIn · 3 known investors
Find your way into BioROSA Technologies
Sign up to find every way you can get introduced to BioROSA Technologies
- Your email: who you already know at BioROSA Technologies, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the BioROSA Technologies team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
MC
Marie CauseyNamed on SEC filing
JS
John SlatteryNamed on SEC filing
Investors · 3
AIFreportedNew York
How we know: a partner's Signal profile · Not right? Tell us
AUTISM IMPACTreportedOrlando
How we know: funding news · Not right? Tell us
IndieBioreportedSan Francisco · $525K
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$3.6M disclosed across 3 rounds · 2019–2022
▶$745KraisedNov 2022 · 8 investors · BiotechnologyRule 506(b)
▶$745KraisedNov 2022 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John SlatteryExecutive Officer, Director
- Christopher JeffersExecutive Officer, Director
- Marie CauseyExecutive Officer, Director
- Offering amount
- $1.6M
- Amount sold
- $745K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2.4MraisedJul 2021 · 16 investors · BiotechnologyRule 506(b)
▶$2.4MraisedJul 2021 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John SlatteryExecutive Officer, Director
- Marie CauseyExecutive Officer, Director
- Offering amount
- $2.4M
- Amount sold
- $2.4M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$450KraisedJul 2019 · 9 investors · BiotechnologyRule 506(b)
▶$450KraisedJul 2019 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Marie CauseyExecutive Officer, Director
- John SlatteryExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $450K
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are BioROSA Technologies's investors?
- BioROSA Technologies's investors include AIF, AUTISM IMPACT, IndieBio.
- How much funding has BioROSA Technologies raised?
- BioROSA Technologies has disclosed $3.6M raised across 3 rounds.
- Where is BioROSA Technologies headquartered?
- BioROSA Technologies is headquartered in Belmont, US.